World Governments Are Expressing Concern That Certain Diabetes Drugs Can Cause Fournier's Gangrene
Governments around the world are requiring companies that make SGLT2 blocker diabetic drugs to add Fournier's Gangrene to the list of serious amputation risks they cause
Monday, April 15, 2019 - Fournier's gangrene is a rare and fatal condition like necrotizing fasciitis of the perineum. The US FDA recently reported that they had discovered 12 cases of Fournier's gangrene in diabetes patients taking a type of medication called SGLT2 blocker. Three more cases of necrotizing fasciitis of the genitals in diabetic patients have been reported through the media but have not officially been classified as of yet as Fournier's by the FDA. Sodium-glucose Cotransporter 2 drugs lower blood sugar by causing the kidneys diverting sugar from the body through the urine. SGLT2 blocker drugs included in the FDA's warning include canagliflozin (Invokana), dapagliflozin (Farxiga), empagliflozin (Jardiance), empagliflozin/linagliptin (Glyxambi), empagliflozin/metformin (Synjardy), dapagliflozin/metformin (Xigduo XR) according to medicinet.com. Diabetes drug infection lawyers recommend speaking to a national Fournier's gangrene attorney offering free consultation before filing a claim.
Governments around the world including the United States and India are requiring that all of these drugs update their product warning literature to include the risk of causing Fournier's gangrene. All of these drugs carry serious amputation and sudden death warnings. In addition to the 12 cases of Fournier's gangrene reported in the US, eight more have been reported to the Indian FDA, the Central Drugs Standard Control Organisation. According to Livemint.com the government of India has followed the lead of the FDA and Canada and is requiring companies to update the warning label on the class of diabetes drugs suspected of causing Fournier's gangrene genital infection.
While some companies have complied and updated their websites to include the new Fournier's gangrene warning, others have been less than forthcoming and instead focus on other more readily occurring side effects. Take Invokana for example. Invokana is the brand name for Canagliflozin used to treat type 2 diabetes, a member of the drug class? called SGLT2 inhibitors and is manufactured and marketed by Janssen Pharmaceuticals. Canagliflozin has been known to cause a condition called Ketoacidosis which can lead to death. Ketoacidosis occurs when the blood becomes too acidic caused by insufficient insulin. The Mayo Clinic reports that diabetic patients taking Canagliflozin should watch for and seek medical treatment if they experience the early signs of Ketoacidosis which include "thirst, frequent urination, nausea, abdominal pain, weakness, fruity-scented breath, and confusion. Hospital treatment to replace fluids and electrolytes and provide insulin therapy may be needed." In addition, the Invokana web site highlights the very real amputation risks Canagliflozin has been known to cause. "Invokana may increase your risk of lower-limb amputations. Amputations mainly involve removal of the toe or part of the foot; however, amputations involving the leg, below and above the knee, have also occurred." Other adverse side effects of Canagliflozin reported in Wikipedia include " vaginal yeast infections, nausea, constipation, and urinary tract infections. Serious side effects may include low blood sugar, leg amputation, kidney problems, high blood potassium, and low blood pressure."
More Recent Diabetes Drug Infection Lawsuit News:
- Heart Disease Patients May Soon Be Prescribed Farxiga | 7/23/2020
- Diabetic Drug Farxiga Emerges As A Potential Cause of Fournier's Gangrene | 7/20/2020
- Diabetic Drug Companies Fail To Adequately Warn Patients of The Dangers of Developing Fournier's Gangrene | 7/15/2020
- A High Profile Fournier's Gangrene Victim May Serve To Increase Public Awareness | 6/25/2020
- The Flesh-Eating Disease Could Grow Exponentially in Summer of 2020 | 6/16/2020
- AstraZeneca Pharmaceutical Web Site Warns Patient About Possible Bacterial Infections | 6/5/2020
- New Fournier's Gangrene Victim Files Lawsuit Against AstraZeneca Pharmaceuticals LP | 6/3/2020
- Fornier's Gangrene is Easily Overlooked And Could be Called Complications From the Coronavirus | 5/26/2020
- Diabetic Nursing Home Patients May Be Dying From Fournier's Gangrene | 5/15/2020
- Diabetic Patients Taking SGLT2 Diabetic Drugs Could Be At Risk of Dying from COVID19 | 4/27/2020
- Fournier's Gangrene Looks Like Frostbite Except For Its Location | 4/21/2020
- Fournier's Gangrene More Likely Than Nursing Home Neglect In Patient's Death | 4/9/2020
- Nursing Homes Need To Pay Attention To Diabetic Patients Developing Fournier's Gangrene | 3/31/2020
- New Warning For SGLT2 Diabetes Drugs Include Fournier's Gangrene | 3/19/2020
- Popular Diabetic Drug Companies Are Warned To Alert Diabetic Patients of the Risks of Developing Fournier's Gangrene | 3/12/2020
- Patient's Fournier's Gangrene Can Be Mistaken For Ordinary Nursing Home Neglect | 3/5/2020
- Nursing Home Patients Taking Diabetic Medication Must Be Monitored For Fournier's Gangrene | 2/25/2020
- Simple Necrotizing Fasciitis Can Lead To Gruesome Fournier's Gangrene | 2/7/2020
- Fournier's Gangrene Can Cause Elephantitis of the Scrotum | 2/3/2020
- Diabetic Drugs Linked to Fournier's Gangrene May Treat Heart Conditions | 1/29/2020
- The Annals of Medicine Examines the Relationship Between Certain Diabetic Drugs and Fournier's Gangrene | 1/8/2020
- Diabetic Medications Can Cause Fournier's Gangrene And Other Health-Threatening Conditions | 12/31/2019
- Fournier's Gangrene Can Leave a Survivor Severely Depressed | 12/20/2019
- Woman's Cosmetic Surgery Leads to Flesh-Eating Disease of the Genitals | 12/16/2019
- Women Diagnosed With Orbital Necrotizing Fasciitis | 12/2/2019
- The Flesh-Eating Disease Has Made The News In 2019 | 11/22/2019
- Diabetic Drugs Can Weaken The Immune System Leading To Fournier's Gangrene | 11/11/2019
- SGLT-2 Drug Makers Are Being More Forthcoming About Links To Fournier's Gangrene | 10/31/2019
- Drug Marketers Are Finding Creative Applications For SGLT-2 Drugs Ignoring The Risk of Fournier's Gangrene | 10/24/2019
- Patient Contracts Flesh-Eating Disease While Giving Birth in a New York Hospital | 10/15/2019
- Weakened Immune Systems May Be The Cause of The Outbreak in Flesh-Eating Disease | 10/3/2019
- Fournier's Gangrene Stories Are One More Shocking Than Then The Last | 10/2/2019
- Sodium-Glucose Blocker Drugs and The Flesh-Eating Disease | 9/18/2019
- Diabetic Patients Are At Risk For Developing Fournier's Gangrene Mistaken as The Ordinary Flesh-Eating Disease | 9/2/2019
- SGLT2 Inhibitor Drugs Can Now Include Reducing Heart Disease on Their Labels In Europe | 8/29/2019
- Fournier's Gangrene Can Develop In Elderly Nursing Home Patients | 8/23/2019
- Elderly Diabetic Patients Are At Risk For Fournier's Gangrene | 8/7/2019
- Florida Nursing Home Death May Have Been From Fournier's Gangrene | 8/1/2019
- There is an Outbreak of The Flesh-Eating Disease Along America's Eastern Beaches | 7/23/2019
- Fournier's Gangrene Should Not Be Confused With Everyday Necrotising Fasciitis | 7/11/2019
- Johnson & Johnson Needs To Do More To Alert Diabetics of The Flesh Eating Disease Caused By Invokana | 6/28/2019
- Diabetic Patients Living in Warmers Climates Are More at Risk to Contract Fournier's Gangrene | 6/13/2019
- The Warm Water Gulf of Mexico May Be a Breeding Ground For The Flesh Eating Disease Bacteria | 6/7/2019
- Diabetic Patients in Nursing Homes Are Ground Zero For Fournier's Gangrene | 5/30/2019
- Several New Cases Of Flesh Eating Disease Have Been Recently Reported | 5/23/2019
- Cases Of Fournier's Gangrene Increases From 12 to 55 In The Latest Peer Reviewed Medical Study | 5/13/2019
- People Are Developing The Flesh-Eating Disease In Various Ways | 4/30/2019
- Most Doctors Remain Unaware of Fournier's Gangrene and May Misdiagnose Patients | 4/19/2019
- Diabetic Drugs Can Have Serious Side Effects | 4/2/2019
- Necrotising Fasciitis Effects Everyone From All Walks of Life | 3/29/2019
- Cases of Fourniers Gangrene Are Steadily Increasing Around The World | 3/25/2019
- Global Warming and Climate Change May Be Contributing to Increases In Flesh Eating Diseases | 3/11/2019
- Early Warning Signs That You May Have Fournier's Gangrene or Other Flesh-Eating Disease | 3/6/2019
- Scientists Are Encouraged By Data From Flesh-Eating Disease Studies | 2/25/2019
- The Brief History of Fournier's Gangrene | 2/20/2019
- FDA and CDC Warn About Flesh-Eating Diseases | 2/18/2019
- Diabetic Drug Warnings Admit to Causing Narcotizing Fasciitis Not Fournier's Gangrene Specifically | 2/11/2019
- Fournier's Gangrene Statistics May Be Greater Than Reported | 2/5/2019
- Diabetic Patients and Others Are At Risk For Fournier's Gangrene | 1/29/2019
- Fournier's Gangrene Frequently Asked Questions | 1/23/2019
- Diabetes Drugs Must Include Fournier's Gangrene Warning | 1/18/2019
- A Nursing Home's Elderly Diabetic Population Most at Risk For Fournier's Gangrene | 1/10/2019
- Diabetic Patients Should Be Vigilant In Watching For The Symptoms Of Fournier's Gangrene, A Flesh-Eating Disease That Can Affect The Genital Region | 1/4/2019
- An Indian Man Has Died of Fournier's Gangrene in a UK Hospital | 12/31/2018
- Pictures of Fournier's Gangrene Are Grotesque and Indescribable | 12/22/2018
- A Florida Nursing Home Patient Death Could be the 13th Case of Fournier's Gangrene | 12/20/2018
- Florida Man Dies From Genital Gangrene Quite Possibly Fournier's Gangrene | 12/15/2018
- The FDA's Fournier's Gangrene Warning is Shocking Diabetes Patients | 12/12/2018
- Drug Websites Carry The Clearest Fournier's Gangrene Amputation Warnings | 12/1/2018
- Recent FDA Warning Alerts Diabetes Patients To Watch For Signs of Genital Flesh-Eating Disease | 11/21/2018
- Diabetes Drugs May Cause Flesh-Eating Disease Affecting The Genitals | 11/1/2018
Lawyers for Fournier's Gangrene
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.